Topic
Founder case studies, SaaS economics, ecommerce, acquisitions, and practical ways to build revenue with AI.
58 articles
Enveda AI drug discovery received a $311 million Series E to advance three clinical-stage medicines and scale PRISM. Early readouts do not establish efficacy.
Read more
Ema enterprise AI agents gained a $77 million Series B. The useful question is whether its workflow teams deliver governed outcomes, not merely more agent activity.
Read more
The IBM AI invisible work study finds validation, correction and exception handling are growing, while oversight skills and incentives lag.
Read more
The AI language coalition brings 60 organizations behind a five-year goal for voice and language access, but governance is still being designed.
Read more
The Tempus Recursion RNA model agreement licenses TxFM for oncology for two years and rewrites a data deal with $42M in committed fees.
Read more
